Literature DB >> 16809381

Acute haemorrhagic conjunctivitis outbreak in the city of Fortaleza, northeast Brazil.

F E A Moura1, D C S Ribeiro, N Gurgel, A C da Silva Mendes, F N Tavares, C N G Timóteo, E E da Silva.   

Abstract

BACKGROUND/AIM: Between February and May 2003 an epidemic of acute haemorrhagic conjunctivitis affected more than 200 000 people in all five geographic regions of Brazil (north, south, midwestern, southeast, and northeast). The aim was to identify the aetiological agent and to describe clinical aspects of this outbreak in a group of patients treated at the ophthalmology department of the Hospital Walter Cantídio (OD-HWC) at the Universidade Federal do Ceará, in the city of Fortaleza, capital of the state of Ceará, northeastern Brazil.
METHODS: Conjunctival swabs were collected from patients who spontaneously went to the laboratory of virology. Specimens were inoculated in HEp-2 and RD cell lines. The viral isolation was confirmed by performing reverse transcriptase polymerase chain reaction and indirect immunofluorescence assay.
RESULTS: Viral conjunctivitis was diagnosed in 56 patients but only 24 of them allowed the collection of samples. Of 24 conjunctival swabs tested, 11 were positive for a variant of coxsackie virus A24 (CA24v) and one of the isolates reacted with anti-adenovirus monoclonal antibodies.
CONCLUSION: CA24v was confirmed as the aetiological agent of this outbreak of acute haemorrhagic conjunctivitis in the city of Fortaleza.

Entities:  

Mesh:

Year:  2006        PMID: 16809381      PMCID: PMC1857380          DOI: 10.1136/bjo.2006.098822

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing.

Authors:  M Steven Oberste; William A Nix; Kaija Maher; Mark A Pallansch
Journal:  J Clin Virol       Date:  2003-04       Impact factor: 3.168

2.  Serologic characterization and sero-epidemiologic studies on acute hemorrhagic conjunctivitis (AHC) virus.

Authors:  R Kono; A Sasagawa; K Miyamura; E Tajiri
Journal:  Am J Epidemiol       Date:  1975-05       Impact factor: 4.897

3.  [Acute hemorrhagic conjunctivitis, in Cuiabá, Mato Grosso, Brazil 1983].

Authors:  E de O Santos; O Macêdo; M de L Gomes; C M Nakauth
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1987 Jan-Feb       Impact factor: 1.846

4.  An epidemic of conjunctivitis in Singapore in 1970.

Authors:  K H Lim; M Yin-Murphy
Journal:  Singapore Med J       Date:  1971-10       Impact factor: 1.858

5.  Acute hemorrhagic conjunctivitis in Puerto Rico, 1981-1982.

Authors:  S H Waterman; R Casas-Benabe; M H Hatch; R E Bailey; R Muõz-Jiménez; R Ramírez-Ramírez; M Rodríguez-Bigas
Journal:  Am J Epidemiol       Date:  1984-09       Impact factor: 4.897

6.  Acute hemorrhagic conjunctivitis outbreak caused by Coxsackievirus A24--Puerto Rico, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-07-23       Impact factor: 17.586

7.  The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan.

Authors:  Cheng-Hsien Chang; Kuei-Hsiang Lin; Min-Muh Sheu; Wen-Loong Huang; Huei-Zu Wang; Chen-Wu Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-27       Impact factor: 3.117

8.  Acute hemorrhagic conjunctivitis epidemic--2003 in Nepal.

Authors:  Reeta Gurung; Shiba Kumar Rai; Manabu Kurokawa; Mohan Krishna Shrestha; Jaya Thakur; Chandra Kala Rai; Sanduk Ruit; Kazuo Ono
Journal:  Nepal Med Coll J       Date:  2003-12

9.  An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia.

Authors:  O Ghazali; K B Chua; K P Ng; P S Hooi; M A Pallansch; M S Oberste; K H Chua; J W Mak
Journal:  Singapore Med J       Date:  2003-10       Impact factor: 1.858

10.  Acute hemorrhagic conjunctivitis and coxsackievirus A24v, Rio de Janeiro, Brazil, 2004.

Authors:  Fernando N Tavares; Eliane V Costa; Silas S Oliveira; Cecilia C A Nicolai; Meri Baran; Edson E da Silva
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

View more
  6 in total

1.  An ex vivo model of coxsackievirus infection using multilayered human conjunctival epithelial cells.

Authors:  Jooeun Lee; Eun Jung Jun; Jung Hae Sunwoo; Eun Soon Kim; Jae-hyung Kim; Jae Yong Kim; Myoung Joon Kim; Yoo Kyum Kim; Heuiran Lee; Hungwon Tchah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-26       Impact factor: 3.117

2.  NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU).

Authors:  Catherine H Schein; Numan Oezguen; Gerbrand J van der Heden van Noort; Dmitri V Filippov; Aniko Paul; Eric Kumar; Werner Braun
Journal:  Peptides       Date:  2010-05-02       Impact factor: 3.750

3.  Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential.

Authors:  Emma C Nilsson; Fariba Jamshidi; Susanne M C Johansson; M Steven Oberste; Niklas Arnberg
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

4.  Molecular characterization and phylogenetic study of coxsackievirus A24v causing outbreaks of acute hemorrhagic conjunctivitis (AHC) in Brazil.

Authors:  Fernando Neto Tavares; Renata de Mendonça Campos; Fernanda Marcicano Burlandy; Rachel Fontella; Maria Mabel Monte de Melo; Eliane Veiga da Costa; Edson Elias da Silva
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

5.  A sialic acid binding site in a human picornavirus.

Authors:  Georg Zocher; Nitesh Mistry; Martin Frank; Irmgard Hähnlein-Schick; Jens-Ola Ekström; Niklas Arnberg; Thilo Stehle
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

6.  Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.

Authors:  Luiz Alfredo Santiago; Jussara Matyelle Rodrigues da Silva; Orleâncio Gomes Ripardo de Azevedo; Paulo Roberto Leitão de Vasconcelos
Journal:  Acta Cir Bras       Date:  2020-02-07       Impact factor: 1.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.